Clinical Trials in Texas

Showing 2341-2360 of 12,973 trials

A Study to Assess the Adverse Events of Intramuscular Injections of AGN-151586 and OnabotulinumtoxinA in Adult Participants for the Change of Glabellar Lines (GL)

NCT06834789

The objective of this Phase 1 study is to assess the safety and efficacy of single treatment of AGN-151586 and of OnabotulinumtoxinA in the glabellar complex of participants with moderate to severe glabellar lines (GL).

Glabellar Lines

AbbVie132 participantsStarted Feb 2025

Scottsdale, Arizona, United States • Newport Beach, California, United States • Redondo Beach, California, United States +5 more locations

RECRUITINGPhase 155 miles

A Phase 1 Study of BHV-1530 in Advanced Solid Tumors

NCT06874335

This is a Phase 1, first in human (FIH), open-label, multicenter study of BHV-1530 in adult participants with advanced or metastatic solid tumors.

Solid Tumor

Biohaven Therapeutics Ltd.95 participantsStarted Mar 2025

Denver, Colorado, United States • Lake Mary, Florida, United States • Detroit, Michigan, United States +9 more locations

A Study to Assess the Adverse Events of Intramuscular Injections of AGN-151586 and OnabotulinumtoxinA in Adult Participants for the Change of Glabellar Lines (GL)

A Phase 1 Study of BHV-1530 in Advanced Solid Tumors

Find Trials by Condition in Texas

The Synergy Disc for the Treatment of 2 Level Cervical Degenerative Disc Disease Compared With Cervical Fusion Surgery

A Switch to Doravirine/Islatravir (DOR/ISL) in Participants With Human Immunodeficiency Virus Type 1 (HIV-1) Who Are Virologically Suppressed on Bictegravir/Emtricitabine/Tenofovir Alafenamide (BIC/FTC/TAF) (MK-8591A-052)

A Study of BMS-986249 Alone and in Combination With Nivolumab in Advanced Solid Tumors

A Study to Assess BOTOX Injections for the Change of Masseter Muscle Prominence in Adult Participants

A Study to Assess the Efficacy, Safety and Tolerability of Different Doses of AZD0780 in Patients With Dyslipidemia

Strategies and Treatments for Respiratory Infections & Viral Emergencies (STRIVE): Shionogi Protease Inhibitor (Ensitrelvir)

Study of SRP-4045 (Casimersen) and SRP-4053 (Golodirsen) in Participants With Duchenne Muscular Dystrophy (DMD)

Study of TNG260 and an Anti-PD Antibody in STK11 Mutated Solid Tumors

Darbepoetin Trial to Improve Red Cell Mass and Neuroprotection in Preterm Infants

Diagnostic and Therapeutic Applications of Microarrays in Liver Transplantation

Study of Brexucabtagene Autoleucel (KTE-X19) in Participants With Relapsed/Refractory Mantle Cell Lymphoma (Cohort 3)

A Study to Evaluate the Efficacy and Safety of Pemigatinib (INCB054828) in Subjects With Myeloid/Lymphoid Neoplasms With FGFR1 Rearrangement - (FIGHT-203)

MARGetuximab Or Trastuzumab (MARGOT)

Study to Assess the Effect of Long-term Treatment With Voxelotor in Participants Who Have Completed Treatment in Study GBT440-031

Talimogene Laherparepvec and Pembrolizumab in Treating Patients With Stage III-IV Melanoma

Efanesoctocog Alfa Prophylaxis in Patients With Hemophilia A With Synovial Hypertrophy

Evaluation of Cognitive Improvement After Bariatric Surgery Using a Virtual Reality Program and the Neuropsi Neuropsychological Battery

A Clinical Study to Assess the Efficacy and Safety of Leriglitazone in Adult Male Subjects With Cerebral Adrenoleukodystrophy